AIPL1 and retinal disorder: The animal model based gene therapy trials for other LCA genes like LCA1 (GUCY2D), LCA4 (AIPL1) and LCA6 (RPGRIP1) are also in progress, which further provides a prospect for the effective treatment regime in inherited blinding retinal disorders [13], [14], [15].